For 1 week, a 34-year-old woman complained of headache, feeling feverish, and being unsure of herself. She attributed these symptoms to stress and anxiety and took two of her husband's alprazolam ...

LA JOLLA, Calif., September 25, 2025--(BUSINESS WIRE)--Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatric diseases, today ...

relationship between anti-NMDA receptor encephalitis and vaccination (or tumors). In addition, it is worth mentioning that HPV can cause cancers, and anti-NMDA receptor encephalitis is associated with ...

When it comes to autoimmune diseases, some parts of the body are thought to be more protected from inflammatory responses than others. The brain is one such place, or at least it was. Scientific ...

OF A LAKE COUNTY TEEN WHO CONTRACTED A RARE DISEASE THAT CAN CAUSE SEIZURES AND HALLUCINATIONS. DIAGNOSING THE DISEASE CAN BE DIFFICULT AND SOME END UP IN A COMA IN JUST WEEKS. WESH TWO’S MARLEI ...

Researchers at DZNE and Charité - Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis. By reprogramming white blood cells to target and eliminate ...

Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease Study ...

Researchers have pioneered a novel treatment for the most common autoimmune encephalitis. By reprogramming white blood cells to target and eliminate disease-causing cells, the approach offers a new ...

NMDAR antibodies are present in serum and CSF, usually with intrathecal synthesis, and are sometimes only detected in the CSF. The main target epitopes are in the NR1/NR2 heteromers of the NMDAR. The ...

LA JOLLA, Calif.--(BUSINESS WIRE)--Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatric diseases, today announced the ...